Senseera is pioneering chromatin-based liquid biopsy to deliver dynamic, tissue-resolved gene expression insights from blood. We focus on liver diagnostics, where current tools fall short, enabling earlier, safer, and more accurate disease detection. Beyond liver, we collaborate with pharma to unlock insights in oncology, immunology, and toxicity — supporting better patient selection, monitoring, and tissue-agnostic MRD, all from a simple blood draw.